Roger Schibli: Catalogue data in Spring Semester 2018 |
| Name | Prof. Dr. Roger Schibli |
| Field | Radiopharmacy |
| Consultation hours | By appointment |
| Address | Inst. f. Pharmazeutische Wiss. ETH Zürich, HCI H 431 Vladimir-Prelog-Weg 1-5/10 8093 Zürich SWITZERLAND |
| Telephone | +41 44 633 74 64 |
| roger.schibli@pharma.ethz.ch | |
| Department | Chemistry and Applied Biosciences |
| Relationship | Full Professor |
| Number | Title | ECTS | Hours | Lecturers | |
|---|---|---|---|---|---|
| 535-0002-00L | Introduction to Pharmaceutical Sciences II | 3 credits | 2V | C. Halin Winter, K.‑H. Altmann, S. M. Ametamey, M. Detmar, J. Hall, S.‑D. Krämer, J.‑C. Leroux, D. Neri, U. Quitterer, R. Schibli, G. Schneider, H. U. Zeilhofer | |
| Abstract | First identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences, which are focused on within the first two years as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities. | ||||
| Learning objective | First identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences, which are focused on within the first two years as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities. | ||||
| Content | Introduction to Pharmaceutical Sciences by selected milestones of research and development. Overview on research activities at the Institute of Pharmaceutical Sciences, which is focused on drug delivery and development (from concepts to prototypes). Sensitization for communication skills and information management. Demonstration of job opportunities in community pharmacies, in the hospital, in industry, and in the public sector by experts in the different fields. | ||||
| Lecture notes | Handouts for individual lectures. | ||||
| Prerequisites / Notice | Interactive teaching | ||||
| 535-0900-00L | Seminars on Drug Discovery and Development | 1 credit | 1K | R. Schibli, K.‑H. Altmann, M. Detmar, C. Halin Winter, J. Hall, J.‑C. Leroux, D. Neri, U. Quitterer, G. Schneider, H. U. Zeilhofer | |
| Abstract | State-of-the-art information on drug discovery and development by experts from academia and industry. | ||||
| Learning objective | State-of-the-art information on drug discovery and development. | ||||
| Content | Seminar series of the Institute of Pharmaceutical Sciences. Experts from academia and industry report on relevant topics. | ||||
| 541-0001-00L | Module 1: Health System, Pharmabusiness and Marketing Only for CAS in Pharmaceuticals. The enrolment is done by the CAS in Pharmaceuticals study administration. | 2.5 credits | 3G | R. Furegati Hafner, R. Schibli | |
| Abstract | Students learn about the different health systems, primarily about the European and the Swiss specialities, then also in comparison with the US system. A short introduction is made about Marketing with focus on Pharma, the legislation and patents/licencing are discussed and pharmacooeconomic aspects and business development are explained and intensified through workshops. | ||||
| Learning objective | Pharmabusiness and Corporate Governance; Pharmamarketing with workshop; Healthcare systems in Switzerland and in the EU; Pharmacoeconomics with workshop; Data integrity for supply chain powered by blockchain; Opinion Leader Management, Workshop; Legislation; Patents and licences; Building Pharma 4.0 – Future Directions; Market Access, Pricing and Reimbursement; Business Development: Connected Health; | ||||
| Lecture notes | Course documents in print and a link to the electronic version are distributed during the module. | ||||
| 541-0003-00L | Module 3: Quality and GMP Only for CAS in Pharmaceuticals. The enrolment is done by the CAS in Pharmaceuticals study administration. | 2.5 credits | 3G | R. Schibli, R. Furegati Hafner | |
| Abstract | |||||
| Learning objective | |||||
| 541-1000-00L | Essay Only for CAS in Pharmaceuticals. The enrolment is done by the CAS in Pharmaceuticals study administration. | 1 credit | 2D | R. Furegati Hafner, R. Schibli | |
| Abstract | The essay is an essential part of the CAS program „Pharmaceuticals – From Research to Market“ (CAS Pharm) and serves as final performance assessment. | ||||
| Learning objective | The essay documents the student’s competence development during the program as well as the transfer of acquired knowledge to professional practice/activities. | ||||
| 542-0002-00L | Module II: Radiopharmaceutical Chemistry Only for CAS in Radiopharmazeutischer Chemie, Radiopharmacy. The enrolment is done by the CAS study administration. | 4 credits | 6G | R. Furegati Hafner, R. Schibli | |
| Abstract | This postgraduate certificate course consists of three 2-week-modules and enables natural scientists to assume responsibility for the small-batch production and quality control of radiopharmaceuticals. Module II: Radiopharmaceutical Chemistry 6 x 4hours of laboratory practice in different locations (PSI, ETH Hönggerberg) | ||||
| Learning objective | • Introduction to radiopharmacy and physics • Radionuclide production • Generator systems • In vitro- and in vivo-characterization of radiolabelled peptides and antibodies • The chemistry of Tc and Re • Kits and pitfalls • Radiopharmaceutical chemistry with halogen isotopes • 18F- and 11C-radiolabelled pharmaceuticals • Chemistry of radiometals other than Tc and Re • Animal and in vitro models • Practical sessions: • Radiolabelling and quality control of antibodies • Mo/Tc-generator and use of kits including quality control and preclinical application • Ge/Ga-generator and 68Ga-radiolabelling of peptides including quality control/video cell labelling • Insight into the routine manufacturing of clinical PET radiopharmaceuticals • 11C- and 18F- radiolabelling for research • In vitro/preclinical characterization of PET radiopharmaceuticals | ||||